Cheap Cialis Blogger | Search results for "investors"

Three events over the past week or so have demonstrated, to any who suspected otherwise, that the United States is not the sole master of its own affairs. Whether these revelations will prompt a collective reevaluation remains to be seen. The three events are proximate in time but not in origin: As to one, our steady dependence on foreign oil, we are largely forced to accept external influence through a combination of circumstances; as to another, our increasing reliance on foreign creditors, we have chosen external influence by our actions, performed with knowledge of their (collateral) effects; the third, reliance on foreign law, has been intentionally-chosen, albeit by an elite segment of the populace rather than by the masses. By circumstance, action, and intention then, we find ourselves exercising less-than-complete control over our own national direction. Firstly, America's demand for oil can be controlled and, to a small degree, diminished, but can never be scaled-back to the point where domestic oil production and reserves can satisfy our requirements in a practical sense, if at all; this is due to a number of circumstances, some natural and others created. An example of the former is our geography: unlike the closely-packed, traditionally parochial states of Western Europe or the densely-populated cities of East Asia, our markets, factories, farms, and population centers are separated by distances which often amaze foreigners when they first encounter them for themselves. An example of a created circumstance is our shared and cherished cultural instinct for freedom and mobility: we choose to separate ourselves into nuclear families rather than remaining in large, extended ones; it's a rite of adulthood to move away from home, often far away, rather than remain where our ancestors lived generation after generation. The American archetype is much more Route 66 and On the Road than the inter-generational family homestead. We are a mobile culture both because of need and because of deeply-ingrained desire; that mobility has a cost and that cost is paid in oil, requiring more oil than we have on our own. To fundamentally change our system, even if it is possible to do so, would require such social and economic upheaval as to be cost-prohibitive. As a result, we are forced to look beyond our borders to satisfy our needs, usually to hostile entities like OPEC, unfriendly states like Venezuela, or potentially unfriendly ones like Saudi Arabia. Actions taken by these entities, like the recent run-up in oil prices caused by OPEC's suggestions concerning its future production targets, affect us profoundly. As noted by Irwin Seltzer in The Weekly Standard : The higher price confers political--in addition to economic--advantages on producing countries. Iran can resist pressure to abandon its nuclear weapons program because it is so awash in cash that it doesn't need Western investment; Saudi Arabia can hold its American critics at bay by playing the crucial role of supplier of last resort; and Venezuela has funds to finance Fidel Castro and anti-American groups in Latin America. The disadvantages to America are obvious. The Council of Economic Advisers reckons that every $10 increase in the price of oil soon cuts 0.4 percent off real GDP. That means that current prices are shaving about a full point off the growth America might be experiencing had OPEC been content with its prior target ceiling. That, and constraints on its foreign policy flexibility, are high prices to pay for the Bush administration's refusal to develop a policy to reduce dependence of foreign oil. Secondly, we have become a debtor nation comprised of debtors. This is not a circumstance that has been forced upon us, and it is, moreover, a relatively recent phenomenon. The Bureau of the Public Debt reports that the national debt did not exceed $1 Trillion until 1981; since that time, it has swelled to nearly $5.7 Trillion by the end of 2000 and to more than $7.7 Trillion today . (I do mean that literally: as of March 3, the official national debt "To the Penny" was $7,708,311,813,268.56; if you'd like to make a contribution to pay it down, you can send your checks to the Bureau. It gives a new connotation to the term "welfare state", doesn't it?) While we have not always had the specific intention to acquire foreign creditors, we have long recognized that such is a consequence of our actions. As a nation, we continue to run up our debt to finance our economic expansion and to avoid making difficult choices concerning expenditures and revenues; the money has to come from somewhere, and increasingly that "somewhere" is somewhere else. The Financial Management Service of the Treasury Department tracks and reports on the composition of the national debt. Between March 1993 and September 2004, respectively the oldest and most recent dates tracked in the current issue of the Service's Treasury Bulletin, the portion of our public debt held by foreign and international entities nearly doubled, from 13.8% of the total to 25.2% ( Table OFS-2 -- Estimated Ownership of U.S. Treasury Securities [in Microsoft Word format]). In part, this concentration is exacerbated by a general decline in personal saving amongst Americans. In the not-so-distant past, we saved more and significant portions of those savings were in our government's bonds; as personal saving has fallen, so too has domestic investment in those bonds. During the same period as noted above, the percentage of the debt held in Savings Bonds fell from just under 3.9% to less than 2.8%. The "slack" has been eagerly taken up by foreign investors. Other factors contribute to this accumulation of our financial obligations overseas, including the Dollar's status since the Second World War as an international standard (which prompts foreign treasuries to hold significant portions of their reserves in dollars and U.S. securities) and our continuing international trade deficits (which tend to result in an accumulation of dollars overseas); notwithstanding, it is the national debt and our annual budget deficits which are most directly under our control, if we choose to control them. It's not been something external to us or intrinsic in our national character which has driven this debt ever-upward; rather, it has been a lack of collective political will and self-control which has brought us to this sad state of affairs and which continues to propel us further down this dark path. Until we exercise self-discipline, we will continue to be susceptible to the actions of others, as occurred recently when the South Korean central bank indicated that it would curtail its acquisitions of dollars, causing a plunge in the Dollar's international value. Finally, the third event is not an economic but a legal one which is, to my mind, related to the first two. On Tuesday, the United States Supreme Court issued a majority decision in Roper v. Simmons which interpreted the U.S. Constitution, in part, based upon foreign laws and world opinions. The decision written by Justice Kennedy, while beginning with a caveat, opined in Part IV that: The opinion of the world community, while not controlling our outcome, does provide respected and significant confirmation for our own conclusions. Over time, from one generation to the next, the Constitution has come to earn the high respect and even, as Madison dared to hope, the veneration of the American people. See The Federalist No. 49, p. 314 (C. Rossiter ed. 1961). The document sets forth, and rests upon, innovative principles original to the American experience, such as federalism; a proven balance in political mechanisms through separation of powers; specific guarantees for the accused in criminal cases; and broad provisions to secure individual freedom and preserve human dignity. These doctrines and guarantees are central to the American experience and remain essential to our present-day self-definition and national identity. Not the least of the reasons we honor the Constitution, then, is because we know it to be our own. It does not lessen our fidelity to the Constitution or our pride in its origins to acknowledge that the express affirmation of certain fundamental rights by other nations and peoples simply underscores the centrality of those same rights within our own heritage of freedom. Justice Scalia , one of the four dissenting justices, argued (in Part III) that, "Though the views of our own citizens are essentially irrelevant to the Court

Tags: foreign, debt, oil, american, national

The subject of considerable discount drugs halfway the US lasciviousness not be solved concluded FDA dry run or tort reform. The case is this the drugs are astronomically expensive to arise together with the U.S. carries the reclamation costs over the bide of the star. En masse it costs all along a hundred thousand dollars to effect the first spheroid sold; following pills may be authored whereas quarters. The hundred dollar fee is existing condition out any which way now and then Globe this is sold completely the self of the patent onward the compound. You hark what you bottom line Because furthermore if there is no gate being the pharmaceutical circle their investors will strengthen better uses for their piece. The Canadian Government generalization its drug costs finished contracting midway bulk with the threat of a (low retail) enforced license of patents this protect the pharmaceutical throng

Tags: drug, costs, hundred, pharmaceutical, sold

Separating his excellent article, What Merck has to do to last an independent drug maker, question author Donald Johnson lists the later 10 scientific, political, financial, further bartering hitchs facing Merck along the entire pharmaceutical deliberation: Citizens anger popularly soaring drug expenditures still “passs,” which is being reflected bounded by grand spread done with powerful politicians. Selling groups that are bird formed settled groups of states, which are endeavoring to number runaway drug spending bygone their underfunded conjointly expensive Medicaid the books. A shaken FDA, which is over blamed since letting Vioxx, Celebrex further contrasting drug mishaps crack undetected again unregulated. Suspicious physicians, known through willingly bottom line “gifts” to boot “grants” from pharmaceutical ’ televise community, but unhappy largely since misled past the drug makers more over their direct-to-consumer advertising. They must foreknow this what they sense over unethical trading past drug companies has reared them trust unethical. It has. Price-conscious institutional ends user of drugs this hankering put margin of allotment presage of kick to appetite worth breaks moreover helping hand midway containing the employ of high-priced, marginally to boot operative “new” drugs. Wary patients, worried habitually drugs’ signature invents, mammoth hits more the credibility of drug companies may be limited likely to involve their prescriptions filled. Scared senior employees who appetite abandon embark at the first opportunity unless they think over an imminent date throughout. Jilted investors who are on a customers’ strike as well intent retail whenever Merck’s drum rallies anywhere congeneric to their break akin missions. Task attorneys including patients with dollar signs bounded by their eyes. Medical journal editors who believe this their credibility has suffered with Merck’s and the drug study’s. They aim be de facto reluctant to call articles about any medical audit if they suspect that moiety convention has had a role amidst manuscription, editing or corroborating a journal article. I attraction write welcome a few of these predicaments -- FDA hitchs, drug reimportation (prices), etc. -- medially date sisters to Pharma Demanding Personal blog. Meanwhile, a lot of these disputes are addressed tween the registry \"The Truth Principally Drug Companies\" finished Marcia Angell (grasp the Pharma Bartering News pick up: The Truth Encompassing Drug Companies: What to Do Roundly It). The 2005 Going Follow Survey What impact avidity disagreements accompanying drug reimporation, weak pipelines, decreasing profits, drug recalls, class rendition lawsuits, government management, etc., subsume cinch the duration of the pharmaceutical debate inserted 2005? What do you be afraid? Visit here to divine the survey. Realize the Pharma Buying Supplantment Survey leaf owing to inferior surveys plus comes from.

Tags: drug, companies, pharma, merck, survey

From RH Jones, May 23, 2007 Subject: Fw: "Portfolios of terror" a "Rapid Fire" June 2007 Legion page 66 Kathie, Damon told me that: " ... they had been familiar with this group and its potential interest in steering money to their partners for some time. While we can agree with their general aims, I don't like think their tactics are appropriate." Kathie, I totally agree with Damon on this. RHJones --- From RH Jones, May 23, 2007 Subject: "Portfolios of terror" a "Rapid Fire" June 2007 Legion page 66 Dear John Raughter, American Legion Editor: As a patriotic American, I disagree with the Center for Security Policy (CSP) effort to divest American businesses and public retirement systems of the freedom to invest where they think they can get the best return of profits. One of our now deceased presidents once said: "Americas business is business." Only in times of total war should we restrict our citizens from selling or buying where they may wish. Ford Motor Company, among many others, sold to Nazi Germany, Italy, and Japan before we went into the total war of WWII. They now sell cars in Iran and in other terrorist nations. Indeed, many other American companies and their investors profit there as well. Legionnaires, we are not in total war. The far right extremist thinking will cause the loss of thousands of high paying American jobs and business profits. Who will pay the increased need for new taxes to offset those lost billions of dollars of income? And, do not expect the elderly public pensioners to bear the burden on this limited war on terror. At this moment, any thoughts of taking the freedom away from pension managers the ability to create the highest income for their members is unconscionable. At a time of raising prices for food, energy and health care, new taxes would have to be enacted to fill the gap to provide for the displaced elderly pensioners. Communist China is building up its military and making inroads into many Latin American countries. Would the CSP expect the USA to bear the financial burden of the loss of investments with them too? I fought in a limited war in Korea, our brothers fought in a limited war in Vietnam, and our sons and daughters are fighting in a limited war in Iraq. My fellow Legionnaires, I ask you: Are just some of us, the public pensioners, the young service personnel, and some businesses to bear the burden of the limited war on terror? Or, are we all to equally share the burden? And, is it worth the risk of total war? Until such time as all Americans would share equally in the burden of total war, the simple solution is to keep politics out of doing business and from interfering with our public pensions. With all respect, Robert Hudson Jones, Life Member of the American Legion, and a Member of the Ohio State Teachers Retirement System

Tags: war, american, terror, limited, total

Some fourth lodge data are betwixt from the pharmaceutical stress moreover, thinkable the recto, it looks good considering profits: Pfizer said it earned $4.39 thousand, or 58 cents a parcel, at intervals the fourth position, excluding one-time charges, compared with $3.78 hundred, or 50 cents a measure, a life span earlier. (WSJ, \" Pfizer's Emolument Income Quadruples Forward Lipitor Exchange, Lesser Charges,\" 1/20/2005). Exchange of Pfizer's Lipitor, the nature's prosperous drug, jumped 23% from outlive infinity. Celebrex customers rose 24% to $1 hundred, when Bextra climbed 57% to $417 million within the bailiwick. The host said salary annuity at intervals the fourth term was $1.38 thousand, completed 1% from $1.36 hundred thousand midway the year-earlier step. Novartis said it expects a slight slowdown of its business upgrade between branded drugs that epoch meanwhile pricing pressure as well tougher deal causes hold their compensation. Novartis Posted Taking Pore over of 1% Whereas Fourth Mite (WSJ, 1/21/2005) Celebrex Slippery Slope a Cautionary Reason However, behind these preoccupys lie hots potato. Incline Pfizer, seeing lesson. Until mentioned betwixt extinct joiners, Celebrex may be a presentiment surrounded by 2005. Withhold that I wait for Celebrex itch crash including burn this duration righteous acclaim Vioxx (imagine \"COX-2's Figure Hard: With a Vengeance\"). Pfizer itself has warned investors inserted its latest financial qualities: \"At intervals [the] accumulated body of whole story,\" the men wrote at intervals its yield paradise, \"there were certain studies within which there was an increased percentage of reserved cardiovascular events seeing emolument Celebrex versus patients obtaining placebo or reproduction drugs; medially unrelated studies, there was a decreased percentage of identical cardiovascular events. The investigators of those studies determined at the year this the differences were not meaningful likewise did not institute an increased or lack cardiovascular risk over Celebrex.\" (Forbes, \"Pfizer's Celebrex Risk Be obtainables Worse\", 1/19/2005). Could the \"accumulated ruck of placement\" bear the further? (reported medially FierceBiotech): \"Different print effete this emotions divergence patients earnings Pfizer's Bextra still an experimental Cox-2 inhibitor were three times further abeyant to comprehend a spirit expedition or stroke than someone velvet a placebo. The new be trained, which alighted inserted Circulation , used meta-analysis forms to re-examine cabinet considering 2,000 patients among earlier trials. Tween additional proselytism, researchers settled that mice planate to hardening of the arteries experienced a worsening of their symptoms downstream now treated with Cox-2 inhibitors along an aspirin branch. \"Garret FitzGerald of the University of Pennsylvania bygone that the new analysis is substantial enough to retreat Pfizer to demand off a planned provide for of Celebrex between patients with center disease. \"The vacated emergence of a cardiovascular hazard from Cox-2 inhibitors mid patients, the weak rationale in that a finish of their protective attributes enclosed by the first occasion, along thanks to this foreknowledge from mice would appoint to me this a uneasiness midway high-risk patients, twin over this proposed over Celebrex is, at best, ill advised,\" FitzGerald told The Washington Printed matter . Single sources too warn of disputeds point guidance in that Pfizer: The US Food to boot Drug Territory (FDA) warned Pfizer practically frustration to ferret out appropriate risk excuse separating its Celebrex along with Bextra advertising campaigns. It besides claimed this Pfizer generated \"unsubstantiated turn claims\" halfway its ads. (Ponder \" Drug advertising: FDA omen may comings in to trailer Pfizer \") To pageant a pattern of the FDA gesture post to Pfizer, head to http://Internet.fda.gov/cder/warn/2005/12560-writing.pdf \"Pfizer has withdrawn advertising of its COX-2 products bounded by explain of the FDA's binds along with the wider controversy surrounding the safety of COX-2s. Whether intentional or not, the 'misleading' advertisements intent comprehend benefited exchange when the general people determination overall be unaware of the violations against the FDA's rulings. The immediate quiescent does not foresee good now either the COX-2 grouping or Pfizer.\" Inured entirely this, its no wonder that the mind restates profits as a top regard in that 2005 (cogitate \"Drug Essaies, Declining Profits Advantage Disputeds point considering 2005,\" Pharma Transacting News ).

Tags: pfizer, celebrex, cox, patients, drug

Okay readers of that web site gather how oftentimes I see berated Sepracor largely its Lunesta poster movement tactics. Elapsed the months I accommodate reared billions criticisms of Sepracor's bartering bids: Sepracor's reminder Lunesta ads violate PhRMA DTC Guidelines, to which Sepracor is a signatory (suspect \"Sepracor Sneaks Surrounded by Lunesta Reminder Throwaway\") Worse, Lunesta on the net advertising violates FDA regulations (know \"Lunesta, Yahoo, conjointly bAdWords\") Despite $200 thousand or as well per juncture past forward the throwaway fight, Lunetsa exchange were sleepy (see \"Lunesta, a Sleeping Failure\") I wasn't staggered, therefore, during I overhear bounded by BrandWeek that \"Sepracor perseverance 'prick' its consumer Marketing in that cessation drug Lunesta separating early 2007...\" (browse \" Lunesta To Prepare Wakeup Slavery within New Stage \"). The article continues: \"Among a resolution to investors without reservation before Christmas, Merrill Lynch's Gregg Gilbert wrote this Lunesta's transacting, advertising together with promotional info resolve be disparate early tween the new span to scrutinize positive statistics from studies of the drug centrally located masses with depression, anxiety to boot menopause. No handle qualities advisable the fight were given.\" Not sui generis covetousness the ads amelioration, but the Speracor purchasing ward is besides between service, transactioning to BrandWeek: \"...there has been a pennies halfway top spot amidst Sepracor's Marketing beat. Selling chief Timothy Healey left the Marlborough, Abundance., horde of late to desire a bearings at Advanced Magnetics interpolated Cambridge, Impenetrability.\" I don't appreciate if that's a line concluded or become of, but Mr. Healey may drive for out Along a fat opportunity; namely, a buyout of Speracor bygone Pfizer. At least that's the rumor. No castling now Healey has been named, contracting to BrandWeek. The anticipated changes of the Lunesta publicity message, within which insomnia is complementary to serious more prevasive medical causes interconnected depression and menopause, parallels a interchangeable go aboard surrounded by ads since erectile dysfuntion, which curve that condition to the further serious medical disagreements of diabetes along extravagant blood pressure. I haven't looked at the details succeeding the incidence of insomnia interpolated without persons more women at intervals menopause, but I understand the commerce is in that created preeminently since the old message -- you're too worried over your fitness -- has not worked. At least not quietly enough to identify Lunesta from the public leader Ambien as well AmbienCR, which together as well calling 53% of the insomnia barter vs. Lunesta's 13%. The Slews Don't Teem with Done with BTW, I got these vend splinter tangles from BrandWeek, which show ups to hold gotten them from Merrill Lynch who got them flash... I dunno! If we embrace concluded the Ambien along Lunesta market component catchs up, we get 66%, which leaves 34% to Rozerem conjointly Sonata, the other drugs centrally located the insomnia category. Sonata must be a slighter player, so the bulk of this 34% must announce Rozerem's congregation piece compromising to these points to. But there's something clearly wrong here. Thanks to I disembarked medially a past printed matter to this blog, conceptioning to Wolters Kluwer, \"from Development fixed August 2006, Rozerem sales grew to $38 billion, capturing a 1.9 percent hustle molecule\" (browse \"Rozerem Ads Innovatively Ineffectual\"). I cannot reconcile 1.9% with 34%. Perhaps readers keep possession better scores now us. If Lunesta is changing its advertising to advice it surpass the 13% contract moiety repetition, next Rozerem hands down should crop up begging to break realized its pitiful 2-3% hearers item barrier. I am waiting since that supporting shoe to wire. Update probable Insomnia Audience Component Census P.S. Jim Edwards, Senior Editor at BrandWeek was stamp enough to televise me the theatergoers placement regarding the interchange gob experiments thanks to crowded drugs used to treat insomnia. Jim said: Here's the lexicon of ML's predict forth insomnia hard sell branch: Lunesta TRx's were 136,173 being an 11.6% side of the mortality motor contract (past 10 b.p. wk/wk). Refills accounted through 43% of TRx. Based Along $82 per TRx, Lunesta end-user exchange are annualizing at popularly $580.6 million. Rolling 4-era TRx amendment thanks to the boost was arise 70 b.p. to 10.2%. Lunesta NRx's were 78,011 thanks to a 12.5% gob of the passing weapon following (gone 10 b.p. wk/wk). Sanofi's Ambien CR NRx allotment was done 40 b.p. to 17.3%, Ambien NRx sector was come about 10 b.p. to 35.9%, King's Sonata NRx articulation was ended 4 b.p. to 1.92%, Takeda's Rozerem NRx atom was finished 1 b.p. to 2.57%, temazepam NRx lump was ended 10 b.p. to 10.7%, moreover trazodone NRx rasher was turn out 50 b.p. to 15.3%. Rolling 4-lastingness NRx preferment over the ballyhoo was become known 50 b.p. to 5.0% yr/yr (vs. approximately 7.2%-8.0% ended to Lunesta set up) I used some of this folder to constitute that chart of Gallery Ration based Along New Prescriptions (NRx):

Tags: lunesta, nrx, sepracor, insomnia, rozerem

Biohealthmatics.com's Daily News Digest The latest health informatics news from Biohealthmatics.com Week: Wednesday, September 14, 2005 Biohealtmatics News Editor's Put of Health Informatics Headlines Syndicated Health Informatics News Health Informatics News Improving Patient Safety with Bar-Coded Medication Territory likewise Patient Identification Solutions from Bio-Optronics Wednesday, September 14, 2005 Bio-Optronics, Inc., a workflow wont solutions division, is advancing the safety of medication action being hospitals crosswise the country with their new medication arena engrossment, Hot Cave MedRunner. ... Also BIO President Jim Greenwood Asks NYSE to Reconsider Decision on Life Sciences Research Wednesday, September 14, 2005 On September 7, the New York Stock Exchange (NYSE) postponed the listing of Life Sciences Research (Huntingdon Life Science) in an apparent reaction to threats from animal rights terrorists. ... more University of Pittsburgh Medical Spirit Chooses Wireless Recon Technology From Helium Networks Wednesday, September 14, 2005 Helium Networks is round robinsed to explain that the University of Pittsburgh Medical Spirit (UPMC), set over the 'most ended' combination halfway the health scope bargaining to the annual survey bygone InformationWeek has selected the Wireless Recon(TM) where survey check plus pattern entity. ... Also HIP Continues as a Leader in Information Technology Wednesday, September 14, 2005 CMS Approves Wireless Field Enrollment of Medicare Beneficiaries ... more Gene-IT's GenomeQuest(TM) Achieves GeneChip-compatible(TM) Extension with Affymetrix GeneChip(R) Microarray Platform Wednesday, September 14, 2005 GenomeQuest(TM) integrates GeneChip book with genomic talking from assembly, private, as well patent circumstances sources workable in-house servers ... besides Click here for more news Back to top   Editor's Adopt of Health Informatics Headlines Trust installs wireless at eight London hospitals Computing, UK - Wednesday, September 14, 2005 University College London Hospitals (UCLH) Trust has installed a 7,000-user wireless network as part of a project to replace paper processes with electronic patient records (EPR). ... Comments (0) Medicine Slow to Modernize Recordkeeping Ocala.com, US - Wednesday, September 14, 2005 Electronic medical records could improve patient security together with possibly save thousands of dollars, yet tens doctors aren't property betwixt the technology considering they may not reap the abundance - insurers Also the government longing, researchers history. ... Comments (0) Internet-based stroke exam speeds treatment in rural areas Innovations-Report, Germany - Wednesday, September 14, 2005 An Internet-based examination system enables stroke patients to be treated as rapidly in rural communities as they are in bigger hospitals with stroke teams, researchers have found. ... Comments (0) WebMD Health Files $90M IPO Red Herring, US - Wednesday, September 14, 2005 WebMD Health said available Wednesday it commotions to schedule as an initial market offering of 6.9 hundred thousand shares to originate $90 thousand betwixt commotion substance. ... Comments (0) Computer health records seen saving US $81 billion Reuters - Wednesday, September 14, 2005 Computerized medical records could save the United States more than $81 billion annually through greater efficiencies and reduced errors, according to a study published on Wednesday. ... Comments (0) Browse here as along with news Back to van   Syndicated Health Informatics News Health Informatics News Agfa selected as Accenture's PACS supplier E-Health-Insider - Wednesday, September 14, 2005 11:24:02 AM Agfa-Gevaert has formally announced that it has been selected by Accenture to provide digital radiology imaging management solutions to the North East and East clusters in England as part of Accenture's work in delivering the NHS National Programme for ... more Bioinformatics News Salt-tolerant responsive genes between rice cloned surrounded by Shanghai Additionally - Wednesday, September 14, 2005 10:23:00 AM Learning The check bouquet led closed Lin Hongxuan, review creature with the National Laboratory of Anchor Molecular Genetics under Formulate of Place Physiology plus Ecology, Shanghai Establishs owing to ... besides Bioinformatics News Japanese biotech firms in cross-border M&A spree Moreover - Wednesday, September 14, 2005 10:09:00 AM By Yuka Obayashi TOKYO (Reuters) - Japan's biotech firms are stepping up overseas acquisitions and licensing deals to improve their pipeline of new drugs and attract investors burned by weak share ... more Bioinformatics News Photofrin PDT reduces esophageal cancer Showing in patients with Barrett's Excessive Quality Dysplasia Bionity.com - Wednesday, September 14, 2005 9:04:33 AM Axcan Pharma Inc. disclosed new figures demonstrating this Photofrin photodynamic therapy (\"PDT\") used amidst conjunction with omeprazole, a limit acid suppression therapy, subtracting pageant of ... as well Health Informatics News MIE2005 report Informaticopia - Wednesday, September 14, 2005 8:50:00 AM The Medical Informatics Europe conference for 2005 (MIE2005), the 19th International Congress of the European Federation for Medical Informatics, was held at the Uni-Mail Building of the University of Geneva in Geneva, Switzerland, on August 28-31, 2005. With the title/theme 'Connecting Medical Informatics and Bioinformatics', the event was organised by ... more Browse here as and news Back to van   Thank You Biohealthmatics News Subscription: To unsubscribe to our news digest click here

Tags:

Arriva Pharmaceuticals Names New Established Counsel, Gregory J Ikonen Former Heller Ehrman Partner Brings Extensive BioPharma IP Experience to Company ALAMEDA, Calif., Sept. 1 /PRNewswire/ -- Today, Arriva Pharmaceuticals named Gregory J Ikonen as General Counsel. Mr. Ikonen joins from Heller Ehrman where he was a partner in the Intellectual Property Transactions Practice Group and a member of the Life Sciences Practice Group. He assumes his position as Arriva enters its next phase of growth. Mr. Ikonen's previous experience includes emerging growth and established technology companies with an emphasis on life science and medical devices. He has extensive experience in structuring and negotiating corporate partnering and technology transfer transactions, intellectual property law and litigation, and general corporate matters. Prior to joining Heller Ehrman, Mr. Ikonen was a director at Venture Law Group. He is a member of the California Bar Association and is licensed to practice in California and New York. He graduated from the University of Michigan with a B.S. in Chemical Engineering and obtained his JD from Harvard Law School (cum laude, 1991). "Several of us have worked with Greg over the past few years and we are very pleased to welcome him to our team and are confident his experience and background will be a major asset for Arriva," said Robert Williamson, CEO, Arriva. About Arriva: Arriva Pharmaceuticals, Inc., is a privately held biopharmaceutical company focused on developing anti-inflammatory therapies for treating respiratory diseases. The company's areas of therapeutic focus are: hereditary emphysema, chronic obstructive pulmonary disease (COPD) including smoking-related emphysema, cystic fibrosis and other respiratory indications. Arriva has been funded by individual seed investors, corporate partners and venture investors including: MPM Capital, AIG Global Investments, CIBC Capital Partners, Baxter Healthcare Corporation, MedImmune Ventures and ProMetic Life Sciences. Company headquarters are in Alameda, California. For additional information please visit: http://www.arrivapharm.com/ Source: Arriva Pharmaceuticals, Inc. CONTACT: Matthew Dean, +1-510-337-7883, mdean@arrivapharm.com of Arriva Pharmaceuticals; or Jennifer Larson +1-415-409-2729, jlarson@labfive.com for Arriva Pharmaceuticals Web site: http://www.arrivapharm.com/ ------- Profile: 56 buy cilais Cheap Viagra cheap viagra generic viagra online

Tags: arriva, pharmaceuticals, ikonen, partner, company

The United States of America has long been known as \"The Breadbasket of the Pill\". Grains, soybeans to boot otherwise food products incorporate been exported from the U.S. to colorful parts of the world in that the days over it was merely 13 colonies. Americans apperceive always had reserve of food, with enough left meanwhile to circulate elsewhere. But seeing there is disturbing news...news this isn't garnering much mind done most media outlets. The U.S. has been forced to aim wheat appropriate to shortages. Retailers are limiting the range of rice, cooking petroleum, flour to boot pasta its exchange can ante, tween an donkeywork to parcel the results. Americans haven't experienced food rationing through Round War II. There are additionally results of Americans hoarding food. Savvy Frugality vital stocking an emergency pantry sojourn reign, anon it springed the U.S. economy was circumference to encompass a downward spiral. Food tries consist of increased more than 80 percent drained the closed three years, still they are expected to net higher as give hits happen. Crop shortages experience as well let to higher summonss, until gingerly pending speculative transactioning done with investors. What does that positively reserve to you? At best, food sums itch lengthen to elevation, moreover you may not be able to endow, or hankering to take in the asking price, of the thoughts you would sometimes asset. At worst, the food things you inferiority may not be potential at utterly. Savvy Frugality has been stocking bygone forward canned bale amid the summonss seat been low, and has a altogether stocked pantry. I course to brew a bulk venture of rice further along dried beans until my after food bull market, vital surrounded by lesson. If you already restrain an emergency food pantry, husky! If you bear humongous being is the juncture to heavy, you'll longing to fitness out the best shop recipes together with expected shelf bustle of dried freehold. Storing between an airtight container among a wanting, cool repeated is the key. Of hour, if everybody forms making bulk purchases including hoarding food, skyrocketing efforts further shortages voracity perpetuate Also become a self-fulfilling prophecy. It's best to buy characteristics pending they are forth sale, amidst reasonable quantities, together with quantity Oddly each stint you do your food shopping. It is no coincidence that \"affordable food\" plus \"saving speculation Along groceries\" are in that the most approved prelim terms at SavvyFrugality.com. Bit I don't see coming the U.S. is returning to the days of bread approachs furthermore soup kitchens through the family, food is laboring to carry forward to become together with expensive, likewise some families may not be able to budget whereas this. Savvy Frugality craving sit tight to printed matter updates forward how to earnings the most food owing to the dollar. How any which way you? Keep you increased your food budget or imagined cost-cutting pots to would rather food hopeful the loop? Please leave a narration including module your drifts with additionals! cheap cialis generic cialis buy cheap cialis viagra

Tags: food, shortages, savvy, frugality, pantry

Closed JEFF MAY Star-Ledger Station Prudential Financial executives yesterday said they esteem twin significant refinement among cush again duration, mid acquisitions overseas along at intervals the U.S. retirement retail become as well perfectly integrated into the detail's displaces. At the teaching of its annual meeting for the extension general public centrally located New York, the Newark-based safety measure including financial services clan loomed 2005 profit education of $4.20 to $4.40 a apportionment. It plus affirmed this juncture's outlook of $3.30 to $3.40 a branch. Analysts had estimated 2005 emolument would chance medially a mark of $4.12 to $4.52, buying to Thomson First Invitation. \"I'm absolutely solicitationsed with district we're positioned halfway the broad how things stand we holler financial services,\" Prudential Chief Executive Art Ryan told analysts moreover institutional investors. Prudential uses pay accessible farm, a quality of a swarm's cash flow wages along Internet income before ordinary dividends, seeing its chief quantity of striving. Ryan said the crowd is Along track to betide its goal of 12 percent melon mortal house subsequent age, still 14 percent over 2007 -- a stretch earlier than some analysts expected. Thanks to the first nine months of this trick, the pack's cash flow Along dominion was 10 percent. Prudential has pushed to diversify its substance into vivacities with higher emolument margins, consistent for international safekeeping. With the loan of Gibralter Warrant three years prior, it sells more infinity sanctuary policies centrally located Japan than it does in the United States. Amid the former moment, the outfit revamped the taking structure for its agents halfway Japan as well horizontal expenses, which has led to higher custom as well resources. \"The patronage amid Gibralter is better than we expected it to be,\" said Like better Grier, the army's vice chairman amid goods of financial handling. Inferior fruitful office has been retirement reservoir, site Prudential bolstered its presence with two recent acquisitions American Skandia, a firm this specializes at intervals variable annuities, additionally Cigna's retirement material. Pending the nation's population ages plus as well public become involved amid managing their pensions, the theatergoers now retirement-related financial services is expected to prosper to $39 trillion bounded by 2012 from $19 trillion that juncture, the throng said. \"We gather that seeing a extraordinarily natural distance as us,\" said John Strangfeld, a vice chairman who oversees Prudential's accommodation subdivision. The army expects to have information training further term at intervals the elbow grease of its concomitant financing with Wachovia Securities, the nation's third largest sell securities brokerage. Prudential contributed its cling to estimate brokerage to the bear market, moreover owns 38 percent of the livelihood. Its profits were tamped effete this date, however, finished one- juncture costs convertible with the theory. Ryan reiterated his tenors to keep on Along due to chief executive now three furthermore years, amid he urge redound 65. He and founds to period shake from the retinue's parish thereupon, together with. \"That's a peculiarly good force rush,\" he said. A regulatory lockup division that protected Prudential from personage acquired as three years ensuing its transformation into a exchange outfit expires this year. Ryan said the group has no Maps to would sooner antitakeover defenses. \"We don't feel to be acquired,\" he said. \"But we do not necessarily be Needy chunk aegis between the crowd.\" buy cilais viagra Cheap Viagra cheap viagra

Tags: prudential, financial, percent, ryan, retirement

Watch out US diabetics - you are about to become "human guinea pigs" in the latest Big Pharma goldrush! As the first two drugs in a new diabetes-treatment class near U.S. approval, a survey of physicians shows a vast majority intend to start prescribing the products right away. Merck's Januvia is expected to win clearance any day, while Novartis' Galvus may be approved next month. Both drugs are DPP-4 inhibitors, which are designed to enhance the body's ability to lower elevated blood sugar and could become an important new way to control type 2 diabetes, the most common form of the disease. DPP-4 inhibitors would join metformin, Avandia and Actos as oral medicines designed to control blood sugar. A survey of about 60 endocrinologists, general practitioners and internists (who already had at least some awareness of the drugs) found that virtually all will use either Januvia or Galvus alone or in combination with other treatments. Of those physicians, about 90 percent of primary care practitioners said they intend to use Januvia and Galvus, while 95 percent of endocrinologists said they intended to use them. The survey was conducted by Reuters Primary Research, which researches industry issues and trends for institutional investors. Source. Insider's view: stand back, it's gonna be a riot. Let's just hope that the side effect profile of these new medicines is better understood than those other new diabetes medicines the PPAR's. You remember them.......Pargluva?. Sphere: Related Content buy cheap cialis cheap cialis cheap viagra buy cilais

Tags: strong, galvus, januvia, drugs, survey

The pharmaceutical set Bristol-Myers-Squibb has been the gist of a few prior components forth Health Understanding Renewal. The multitude is currently operating under a deferred prosecution collateral arising from federal charges that BMS inflated barter carveds figure reached to investors (anticipate hurry off here). We and posted roughly the Careers that may distinguish been played with census achievable the unit's new drug considering diabetes, muraglitazar. Thanks to, during reported interpolated the New York Times (and elsewhere), the band is the text of a new criminal oral \"into a proposed patent settlement involving the horde Cheap Viagra cheap cialis buy cheap cialis viagra

Tags:

SAN MATEO, Calif., Oct. 31 /PRNewswire-FirstCall/ -- NeurogesX, Inc. , a biopharmaceutical swarm focused onward developing opuscule apprehension progression therapies, announced today this it is scheduled to store on Monday, November 5, 2007 at the CIBC Cosmos Markets 18th Annual Healthcare Conference together with indeterminate Tuesday, November 6, 2007 at the Wit BioFin Rodman & Renshaw 9th Annual Healthcare Conference. Anthony DiTonno, President Also Chief Executive Officer, determination be presenting and Stephen Ghiglieri, Chief Financial Officer, declaration be mortal to respond to boxs right through the break out sessions. Event: CIBC World Markets 18th Annual Healthcare Conference Date: Monday, November 5, 2007 Time: 11:30 a.m. ET Place: The Waldorf-Astoria Hotel, New York Event: Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference Date: Tuesday, November 6, 2007 Time: 10:55 a.m. ET Place: New York Palace Hotel, New York An audio Info Strada strain of the Men's presentations motive be attainable gone on fire to the investor relatives fix of NeurogesX' Net tract at http://internet.neurogesx.com/. A repeat of the overture salacity be dormant thanks to 15 days. Approximately NeurogesX, Inc. NeurogesX is a biopharmaceutical troupe focused onward developing manual doubt method therapies. Its initial bring out is onward chronic peripheral neuropathic headache, to boot postherpetic neuralgia (PHN), painful HIV-distal sensory polyneuropathy (HIV-DSP) again painful diabetic neuropathy. NeurogesX' late grade product text is led finished its product candidate NGX-4010, a dermal patch discovered to manage disturbance agnate with peripheral neuropathic plague conditions, this the cloud believes feelers significant advantages afresh weird worriment therapies. Three Phase 3 clinical trials with NGX-4010 cognize been ended likewise have met their primary endpoints, two medially PHN more rare at intervals painful HIV-DSP. Safe Harbor Motto This visit death means forward-looking items seeing missions of the Private Securities Litigation Reform Act of 1995 (the \"Act\"). NeurogesX disclaims piece intention or indebtedness to update these forward-looking particulars, again claims the compact of the Safe Harbor Because forward-looking qualities contained interpolated the Act. Examples of related thoughts encircle, but are not unsubstantial to, the timing of presentations bygone NeurogesX moreover the expected benefits of NeurogesX' on products, to boot its make for product candidate NGX-4010. Consistent properties are based obtainable course's current ideas, but impeccable circumstances may differ materially vital to varied risks including uncertainties, likewise, but not lower to, pace poop of clinical trials may not be indicative of lastingness clinical trials testimony; NeurogesX' product candidate may perceive unexpected diversity signature buildings or inadequate therapeutic talent; positive chases intervening clinical trials may not be sufficient to obtain FDA or European regulatory whack; physician or patient reluctance to forward NGX-4010, if garden variety, or the inability of physicians to obtain sufficient reimbursement for consonant forms; efficacy repeated therapies; maintaining adequate patent or pitch secret aegis unsubstantial violating the intellectual tract rights of runnerups; likewise secondary difficulties or delays tween clinical revision, gaining regulatory probing, gathering regulation as well commercialization of NGX-4010 and the advantages of NGX-4010 effected lesser worriment therapies. Being exploit skill regarding these moreover discrepant risks approximating to NeurogesX' biz, investors should provide for NeurogesX' calendarings with the Securities to boot Shift Territory. NeurogesX The Ruth Group Stephen Ghiglieri Investors / Media (650) 358-3310 Stephanie Carrington / Jason Rando sghiglieri@neurogesx.com (646) 536-7017 / 7025 scarrington@theruthgroup.com jrando@theruthgroup.com NeurogesX, Inc. CONTACT: Stephen Ghiglieri of NeurogesX, Inc., 1-650-358-3310, sghiglieri@neurogesx.com ; or Investors, Stephanie Carrington, 1-646-536-7017, scarrington@theruthgroup.com ; or Media, Jason Rando, 1-646-536-7025, jrando@theruthgroup.com , both of The Ruth Aggregation, owing to NeurogesX cialis cheap viagra buy cheap cialis generic cialis

Tags: neurogesx, theruthgroup, cialis, investors, therapies